Publications Breadcrumb Home Publications Since we carefully research publications with DZIF affiliation before posting them on the DZIF website, there is usually a delay of two to three months between a paper's publication date and its listing on the DZIF publications website. Show filterHide filter All years of publication All years of publication20122013201420152016201720182019202020212022202320242025 All research areas All research areasCommunity-Acquired Infections at Mucosal InterfacesHepatitisHIVInfections of the Immunocompromised HostHealthcare-Associated InfectionsMalaria and Neglected Tropical DiseasesEmerging InfectionsNovel AntibioticsTuberculosis All infrastructures All infrastructuresBioresources, Biodata and Digital HealthDZIF AcademyClinical Trial UnitProduct Development Jan 2022 PLoS Pathog Advances and gaps in SARS-CoV-2 infection models Autoren Muñoz-Fontela C et al. Jan 2022 Mol ther Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors Autoren Becker J et al. Jan 2022 Commun Biol SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB Autoren Neufeldt CJ et al. Jan 2022 Chem Sci Total synthesis and mechanism of action of the antibiotic armeniaspirol A Autoren Arisetti N et al. Jan 2022 Clin Exp Immunol Deciphering the Plasmodium falciparum malaria-specific CD4+ T cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer Autoren Schulte S et al. Jan 2022 PLoS Pathog Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection Autoren Sohail A et al. Jan 2022 J Virol Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors Autoren Richter E et al. Jan 2022 J Antimicrob Chemother An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones Autoren Vehreschild M et al. Jan 2022 Nat Commun Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Autoren Koerber N et al. Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T Jan 2022 Parasitol Res A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs Autoren Schlabe S et al. Jan 2022 Hepatology HCC and HBV reactivation-A preventable condition not to be missed Autoren Sandmann L Cornberg M Jan 2022 Bioorg Med Chem Lett Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part Autoren Megahed SH et al. Jan 2022 Front Immunol Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention Autoren Wagh K et al. Jan 2022 Cell Mol Immunol MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Autoren Kim Y et al. Jan 2022 Cell mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al. Jan 2022 Gut Pathog Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis Autoren Brauer M et al. Jan 2022 Org Lett Discovery of a Cryptic Nitro Intermediate in the Biosynthesis of the 3-(trans-2'-Aminocyclopropyl)alanine Moiety of Belactosin A Autoren Engelbrecht A et al. Jan 2022 Ann Hematol Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the AGIHO of the DGHO on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus Autoren Henze L et al. Jan 2022 PLoS Pathog Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs Autoren Gestuveo RJ et al. Jan 2022 Chemistry Sandacrabins - Structurally Unique Antiviral RNA Polymerase Inhibitors from a Rare Myxobacterium Autoren Bader CD et al. Jan 2022 Front Cell Infect Microbiol Filarial Lymphedema Patients Are Characterized by Exhausted CD4+ T Cells Autoren Horn S et al. Jan 2022 Microbiol Spectr SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests Autoren Lindner AK et al. Jan 2022 J Mater Chem B Targeting extracellular lectins of Pseudomonas aeruginosa with glycomimetic liposomes Autoren Metelkina O et al. Jan 2022 Immunity Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization Autoren Weber T Potthoff J [...] Klein F Pagination Previous page ‹‹ Seite 107 Seite 108 Seite 109 Seite 110 Current page 111 Seite 112 Seite 113 Seite 114 Seite 115 Seite 107 Seite 108 Seite 109 Seite 110 Seite 111 Seite 112 Seite 113 Seite 114 Seite 115 Next page ››
Jan 2022 Mol ther Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors Autoren Becker J et al.
Jan 2022 Commun Biol SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB Autoren Neufeldt CJ et al.
Jan 2022 Chem Sci Total synthesis and mechanism of action of the antibiotic armeniaspirol A Autoren Arisetti N et al.
Jan 2022 Clin Exp Immunol Deciphering the Plasmodium falciparum malaria-specific CD4+ T cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer Autoren Schulte S et al.
Jan 2022 PLoS Pathog Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection Autoren Sohail A et al.
Jan 2022 J Virol Reduction of CD8 T cell functionality but not inhibitory capacity by integrase inhibitors Autoren Richter E et al.
Jan 2022 J Antimicrob Chemother An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones Autoren Vehreschild M et al.
Jan 2022 Nat Commun Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents Autoren Koerber N et al.
Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T
Jan 2022 Parasitol Res A qPCR to quantify Wolbachia from few Onchocerca volvulus microfilariae as a surrogate for adult worm histology in clinical trials of antiwolbachial drugs Autoren Schlabe S et al.
Jan 2022 Hepatology HCC and HBV reactivation-A preventable condition not to be missed Autoren Sandmann L Cornberg M
Jan 2022 Bioorg Med Chem Lett Novel 2,4-disubstituted quinazoline analogs as antibacterial agents with improved cytotoxicity profile: Modification of the benzenoid part Autoren Megahed SH et al.
Jan 2022 Front Immunol Editorial: Novel Concepts in Using Broadly Neutralizing Antibodies for HIV-1 Treatment and Prevention Autoren Wagh K et al.
Jan 2022 Cell Mol Immunol MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Autoren Kim Y et al.
Jan 2022 Cell mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Autoren Garcia-Beltran WF et al.
Jan 2022 Gut Pathog Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis Autoren Brauer M et al.
Jan 2022 Org Lett Discovery of a Cryptic Nitro Intermediate in the Biosynthesis of the 3-(trans-2'-Aminocyclopropyl)alanine Moiety of Belactosin A Autoren Engelbrecht A et al.
Jan 2022 Ann Hematol Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the AGIHO of the DGHO on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus Autoren Henze L et al.
Jan 2022 PLoS Pathog Mutational analysis of Aedes aegypti Dicer 2 provides insights into the biogenesis of antiviral exogenous small interfering RNAs Autoren Gestuveo RJ et al.
Jan 2022 Chemistry Sandacrabins - Structurally Unique Antiviral RNA Polymerase Inhibitors from a Rare Myxobacterium Autoren Bader CD et al.
Jan 2022 Front Cell Infect Microbiol Filarial Lymphedema Patients Are Characterized by Exhausted CD4+ T Cells Autoren Horn S et al.
Jan 2022 Microbiol Spectr SARS-CoV-2 Variant of Concern B.1.1.7: Diagnostic Sensitivity of Three Antigen-Detecting Rapid Tests Autoren Lindner AK et al.
Jan 2022 J Mater Chem B Targeting extracellular lectins of Pseudomonas aeruginosa with glycomimetic liposomes Autoren Metelkina O et al.
Jan 2022 Immunity Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization Autoren Weber T Potthoff J [...] Klein F
